Response to comment on “International consensus recommendations for the use of prolonged-infusion β-lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the Infectious Diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists”

Lisa T. Hong; Kevin J. Downes; Alireza FakhriRavari; Jacinda C. Abdul-Mutakabbir; Joseph L. Kuti; Sarah Jorgensen; David C. Young; Mohammad H. Alshaer; Matteo Bassetti; Robert A. Bonomo; Mark Gilchrist; Soo Min Jang; Thomas Lodise; Jason A. Roberts; Thomas Tängdén; Athena Zuppa; Marc H. Scheetz

doi:10.1002/phar.2907

Response to comment on “International consensus recommendations for the use of prolonged-infusion β-lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the Infectious Diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists”

Lisa T. Hong, Kevin J. Downes, Alireza FakhriRavari, Jacinda C. Abdul-Mutakabbir, Joseph L. Kuti, Sarah Jorgensen, David C. Young, Mohammad H. Alshaer, Matteo Bassetti, Robert A. Bonomo, Mark Gilchrist, Soo Min Jang, Thomas Lodise, Jason A. Roberts, Thomas Tängdén, Athena Zuppa, Marc H. Scheetz

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	208-209
Number of pages	2
Journal	Pharmacotherapy
Volume	44
Issue number	2
DOIs	https://doi.org/10.1002/phar.2907
State	Published - Feb 2024

ASJC Scopus Subject Areas

Pharmacology (medical)

Keywords

United States
Cystic Fibrosis/drug therapy
Humans
Pharmacy
Critical Care
beta-Lactams
Pharmacists
Communicable Diseases
Consensus
Anti-Infective Agents

Access to Document

10.1002/phar.2907

OpenUrl availability

Full text

Cite this

Hong, L. T., Downes, K. J., FakhriRavari, A., Abdul-Mutakabbir, J. C., Kuti, J. L., Jorgensen, S., Young, D. C., Alshaer, M. H., Bassetti, M., Bonomo, R. A., Gilchrist, M., Jang, S. M., Lodise, T., Roberts, J. A., Tängdén, T., Zuppa, A., & Scheetz, M. H. (2024). Response to comment on “International consensus recommendations for the use of prolonged-infusion β-lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the Infectious Diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists”. Pharmacotherapy, 44(2), 208-209. https://doi.org/10.1002/phar.2907

Response to comment on “International consensus recommendations for the use of prolonged-infusion β-lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the Infectious Diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists”. / Hong, Lisa T.; Downes, Kevin J.; FakhriRavari, Alireza et al.
In: Pharmacotherapy, Vol. 44, No. 2, 02.2024, p. 208-209.

Research output: Contribution to journal › Letter › peer-review

Hong, LT, Downes, KJ, FakhriRavari, A , Abdul-Mutakabbir, JC, Kuti, JL, Jorgensen, S, Young, DC, Alshaer, MH, Bassetti, M, Bonomo, RA, Gilchrist, M, Jang, SM, Lodise, T, Roberts, JA, Tängdén, T, Zuppa, A & Scheetz, MH 2024, 'Response to comment on “International consensus recommendations for the use of prolonged-infusion β-lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the Infectious Diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists”', Pharmacotherapy, vol. 44, no. 2, pp. 208-209. https://doi.org/10.1002/phar.2907

Hong LT, Downes KJ, FakhriRavari A , Abdul-Mutakabbir JC, Kuti JL, Jorgensen S et al. Response to comment on “International consensus recommendations for the use of prolonged-infusion β-lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the Infectious Diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists”. Pharmacotherapy. 2024 Feb;44(2):208-209. doi: 10.1002/phar.2907

Hong, Lisa T. ; Downes, Kevin J. ; FakhriRavari, Alireza et al. / Response to comment on “International consensus recommendations for the use of prolonged-infusion β-lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the Infectious Diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists”. In: Pharmacotherapy. 2024 ; Vol. 44, No. 2. pp. 208-209.

@article{49e54a938eb5464ab4e7232948521b92,

title = "Response to comment on “International consensus recommendations for the use of prolonged-infusion β-lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the Infectious Diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists”",

keywords = "United States, Cystic Fibrosis/drug therapy, Humans, Pharmacy, Critical Care, beta-Lactams, Pharmacists, Communicable Diseases, Consensus, Anti-Infective Agents",

author = "Hong, {Lisa T.} and Downes, {Kevin J.} and Alireza FakhriRavari and Abdul-Mutakabbir, {Jacinda C.} and Kuti, {Joseph L.} and Sarah Jorgensen and Young, {David C.} and Alshaer, {Mohammad H.} and Matteo Bassetti and Bonomo, {Robert A.} and Mark Gilchrist and Jang, {Soo Min} and Thomas Lodise and Roberts, {Jason A.} and Thomas T{\"a}ngd{\'e}n and Athena Zuppa and Scheetz, {Marc H.}",

year = "2024",

month = feb,

doi = "10.1002/phar.2907",

language = "English",

volume = "44",

pages = "208--209",

journal = "Pharmacotherapy",

issn = "0277-0008",

number = "2",

}

TY - JOUR

T1 - Response to comment on “International consensus recommendations for the use of prolonged-infusion β-lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the Infectious Diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists”

AU - Hong, Lisa T.

AU - Downes, Kevin J.

AU - FakhriRavari, Alireza

AU - Abdul-Mutakabbir, Jacinda C.

AU - Kuti, Joseph L.

AU - Jorgensen, Sarah

AU - Young, David C.

AU - Alshaer, Mohammad H.

AU - Bassetti, Matteo

AU - Bonomo, Robert A.

AU - Gilchrist, Mark

AU - Jang, Soo Min

AU - Lodise, Thomas

AU - Roberts, Jason A.

AU - Tängdén, Thomas

AU - Zuppa, Athena

AU - Scheetz, Marc H.

PY - 2024/2

Y1 - 2024/2

KW - United States

KW - Cystic Fibrosis/drug therapy

KW - Humans

KW - Pharmacy

KW - Critical Care

KW - beta-Lactams

KW - Pharmacists

KW - Communicable Diseases

KW - Consensus

KW - Anti-Infective Agents

UR - http://www.scopus.com/inward/record.url?scp=85185124046&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85185124046&partnerID=8YFLogxK

UR - https://www.mendeley.com/catalogue/8e39444d-b7de-3742-806b-fdd2039a79ae/

U2 - 10.1002/phar.2907

DO - 10.1002/phar.2907

M3 - Letter

C2 - 38362632

AN - SCOPUS:85185124046

SN - 0277-0008

VL - 44

SP - 208

EP - 209

JO - Pharmacotherapy

JF - Pharmacotherapy

IS - 2

ER -

ASJC Scopus Subject Areas

Keywords

Access to Document

OpenUrl availability

Other files and links

Cite this